Summary

European countries have a well-established healthcare infrastructure, characterized by universal healthcare coverage and a focus on early detection and management of health conditions. Blood pressure monitoring devices are integral tools for healthcare professionals across various settings, aiding in the diagnosis, treatment, and long-term tracking of cardiovascular health. As a result, the demand for accurate and user-friendly blood pressure devices remains consistently high. Innovation is a hallmark of the European medical technology landscape. The region is home to numerous medical device manufacturers and research institutions dedicated to developing cutting-edge blood pressure monitoring technologies. These innovations often integrate digital features, such as wireless connectivity, data storage, and remote monitoring capabilities, aligning with the trend of digitization in healthcare. As Europe's aging population seeks to maintain an active lifestyle, blood pressure monitoring becomes not only a necessity but a means to empowerment. This palpable shift in attitude has catalyzed the expansion of the blood pressure device market, with manufacturers vying to offer diverse options to suit every need. The result is an array of devices that transcend traditional medical settings, allowing individuals to monitor their blood pressure at their convenience, whether at home, on the go, or even during travel.

According to the research report "Europe Blood Pressure Monitoring Devices Market Outlook, 2028," published by Bonafide Research, the Europe Blood Pressure Monitoring Devices market is expected to add USD 820 Million from 2023 to 2028. The blood pressure monitoring device market in Europe is expanding rapidly, and it has become one of the key players in the world of medical technology. Europe has established itself as a prominent participant in the creation, dissemination, and use of cutting-edge blood pressure monitoring technologies, with a number of factors supporting its growth. The region's healthcare emphasis on preventive care, coupled with a growing awareness of cardiovascular health, has driven the demand for accurate and accessible blood pressure monitoring devices. As populations become more health-conscious and seek ways to manage hypertension and related conditions, the market for these devices has expanded substantially. Government initiatives across various European nations have also catalyzed the growth of the blood pressure monitoring device market. Policies promoting telemedicine, remote patient monitoring, and personalized health management align with the capabilities of modern blood pressure devices. The region's healthcare systems are increasingly adopting digital tools to improve patient outcomes and optimize healthcare delivery. Furthermore, Europe's strong regulatory environment ensures that blood pressure monitoring devices adhere to stringent quality and safety standards. This commitment to excellence builds trust among both healthcare professionals and patients, bolstering the adoption of these devices. The European Society of Hypertension (ESH) has taken an active role in promoting the use of blood pressure monitoring devices among the public as part of its commitment to raising awareness about hypertension and improving cardiovascular health.

Based on the report, The Europe Market is segmented into countries like Germany, United Kingdom, France, Spain, Italy, and Russia. Among them, United Kingdom (UK) has established itself as a dominant player in the global blood pressure monitoring device market. Renowned for its advanced medical technology sector and a commitment to enhancing patient care, the UK's robust healthcare infrastructure, characterized by a combination of public and private healthcare services, provides a fertile ground for the adoption of cutting-edge medical technologies. Germany and France have emerged as significant growth drivers in the blood pressure monitoring device market, showcasing their prowess in medical technology innovation, healthcare infrastructure, and proactive public health strategies. German companies are at the forefront of creating devices that integrate digital capabilities, ensuring seamless data transmission, remote monitoring, and compatibility with telemedicine platforms. Italy as a growing country shares the fastest CAGR.

In a decisive move reflecting Europe's commitment to environmental sustainability and public health, the region has implemented a ban on mercury-based blood pressure monitoring devices. This prohibition signifies a significant step towards safeguarding both the well-being of individuals and the planet. Mercury, a potent neurotoxin, poses serious health risks upon exposure, particularly affecting vulnerable populations such as pregnant women, children, and the elderly. By discontinuing the use of mercury-filled sphygmomanometers, Europe is sending a clear message that the health of its citizens is paramount and must not come at the cost of environmental degradation. The ban is in alignment with the global shift towards safer and more sustainable healthcare practices. Manufacturers are now compelled to develop alternative, non-toxic technologies that uphold the accuracy and reliability demanded in medical measurements. This transition is fostering innovation within the medical device industry, paving the way for digital and aneroid blood pressure monitors to take center stage.

Based on the device types the market is further categorized into Aneroid/ Sphygmomanometer BP Monitor, Automated/Digital, BP Transducers, Blood Pressure Instrument Accessories (BP Cuff, Bladders, Bulbs and Valves), Ambulatory BP Monitors. In terms of the most commonly used type of blood pressure machine in Europe, digital automatic monitors remains a prevalent choice. These devices combine accuracy with user-friendly features, making them suitable for both clinical settings and home use. Their ease of use and consistent results has made them a staple for individuals of all ages seeking regular blood pressure measurements. However, the rise of wearable wrist monitors is also notable, especially among tech-savvy consumers looking for convenience without sacrificing accuracy. The trend of adopting digital blood pressure monitoring devices in European countries reflects the region's commitment to leveraging technology for better healthcare outcomes. As these devices continue to evolve with features that cater to user needs and align with healthcare strategies, their integration into everyday health practices is likely to grow, further empowering individuals to take charge of their cardiovascular health. The European blood pressure accessories and transducers market is shaped by factors such as technological innovation, quality assurance standards, and the demand for accurate and user-friendly monitoring solutions. Medical device manufacturers continuously develop and refine accessories and transducers to meet evolving healthcare requirements, integrate with digital health ecosystems, and enhance patient comfort during blood pressure measurement. Additionally, regulatory standards and certifications in Europe emphasize the importance of accuracy and safety, further influencing the design and production of accessories and transducers. Healthcare professionals and institutions prioritize equipment that adheres to these standards, contributing to the market's emphasis on quality and reliability.

Based on the Automated/ Digital Blood Pressure Monitoring Devices Type, the market is segmented into 3 categories: Upper Arm, Wrist, and Finger. In the landscape of blood pressure monitoring devices in Europe, wrist blood pressure monitoring devices have been experiencing the highest CAGR, reflecting a notable shift in consumer preferences and technological advancements. This trend underscores the changing dynamics of health monitoring, the influence of innovation, and the evolving needs of individuals seeking convenient ways to manage their cardiovascular health. But, the upper arm is a preferred location for blood pressure measurements because it provides a stable and consistent point of measurement. This region is closer to the heart and major arteries, resulting in more accurate readings that closely reflect the actual blood pressure levels within the circulatory system. Digital upper arm blood pressure monitors have become particularly popular due to their ease of use. Wrist and finger blood pressure devices are though the alternative types of blood pressure monitoring tools that offer unique advantages and conveniences compared to the more traditional upper arm devices. While they have gained some popularity, wrist and finger devices are generally considered to have certain limitations and may not always provide readings as accurate as those obtained from upper arm monitors.
Based on Automated/ Digital Blood Pressure Monitoring Devices Technology Type, the market is segmented into Non-Smart/ Wired and Smart/ Wireless. The adoption of wired and wireless blood pressure monitoring devices in Europe is influenced by a range of factors. Clinical settings tend to prioritize wired devices for their established accuracy and seamless integration with existing healthcare systems. On the other hand, the wireless segment is driven by technological advancements, consumer demand for remote monitoring solutions, and the rise of digital health applications. The choice between wired and wireless devices often depends on the specific use case, healthcare setting, and desired level of connectivity. While wired devices remain essential for clinical accuracy, wireless devices offer individuals greater flexibility, enabling them to monitor their blood pressure at home and share data with healthcare providers for remote monitoring and timely interventions.

The blood pressure monitoring equipment market in Europe has been dominated by the home healthcare sector. This evolution is a result of a broader shift toward patient-centered care, technological advancements, and the empowerment of people to actively manage their health, particularly their cardiovascular health. In the healthcare landscape of Europe, the hospital pharmacies segment has established itself as a dominant player, commanding the largest share in the distribution of medical products, including blood pressure monitoring devices. Hospital pharmacies offer several advantages, such as immediate access to medical professionals, integration with patient records, and the ability to provide specialized care and guidance. This prominence is attributed to the critical role hospitals play in acute care, specialized treatments, and comprehensive medical services. However, the landscape of healthcare purchasing is evolving, and the retail pharmacy and online segments are witnessing substantial growth. The convenience of retail pharmacies, often located within communities, appeals to patients seeking quick access to over-the-counter medical devices, including blood pressure monitors. Moreover, retail pharmacies provide a bridge between hospital care and routine health management, allowing patients to continue monitoring their health post-hospitalization. The online purchase of medical devices, including blood pressure monitoring devices, is experiencing significant growth due to technological advancements and changing consumer behaviors. Online platforms offer a vast selection, competitive pricing, and the convenience of doorstep delivery. This trend is further accelerated by the increasing adoption of telemedicine and remote patient monitoring, where patients can purchase devices online and share data with healthcare providers electronically.

The COVID-19 pandemic has had a multifaceted impact on the blood pressure device market in Europe, reshaping consumer behavior, healthcare practices, and technological innovation. With the pandemic emphasizing the importance of proactive health management, the demand for blood pressure monitoring devices experienced a notable surge. As individuals became more conscious of their well-being, there was a heightened interest in tracking cardiovascular health from the comfort of their homes. The closure of healthcare facilities and the reluctance to visit clinics due to infection concerns accelerated the adoption of remote monitoring solutions. Telehealth and virtual consultations became pivotal, prompting a greater reliance on blood pressure devices that could seamlessly transmit accurate readings to healthcare providers. As a result, there was a notable shift towards smartphone-connected devices and wearable’s that enabled individuals to share real-time data with medical professionals. On the flip side, disruptions in global supply chains and manufacturing processes caused temporary challenges in the availability of certain devices. Despite these hurdles, the market exhibited resilience, adapting swiftly to meet the increased demand and evolving needs of consumers.

Start-up’s scenarios

• A smart-ring medical device is emerging as an effective and discreet wearable for round-the-clock blood pressure monitoring. Using photoplethysmography (PPG) signals to measure the bloodstream 24/7 through the wearer’s finger, a new feature of the “Cart-I plus” ring from manufacturer Sky Labs enables it to constantly monitor hypertension without user intervention.

• Blinx Health is a French startup that has developed a wearable blood pressure monitor. Their device uses patented technology to measure blood pressure from the wrist, providing continuous and non-invasive monitoring.

• Quantum Operation is a German startup that combines photonics and AI to develop innovative medical devices, including a non-invasive blood pressure monitor. Their technology aims to provide accurate measurements without the need for cuffs.

• Huma, formerly known as Medopad, is a UK-based health technology company that offers remote patient monitoring solutions. While not solely focused on blood pressure, their platform includes monitoring and management of various health metrics, including blood pressure.

Companies Covered in the report:

Omron Corporation, Koninklijke Philips N.V., Welch Allyn, Inc., Panasonic Holdings Corporation, Halma plc, General Electric Company, Masimo Corporation, Microlife Corporation, Nihon Kohden Corporation, Drägerwerk AG & Co. KGaA, Spacelabs Healthcare, A&D Company, Limited, ICU Medical, Inc, Withings, Beurer GmbH, American Diagnostic Corporation and Rossmax International Ltd.

Considered in this report:

• Geography: Europe
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Europe Blood Pressure Monitoring Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Device:

• Aneroid/ Sphygmomanometer BP Monitor
• Automated/Digital
• BP Transducers
• Blood Pressure Instrument Accessories (BP Cuff, Bladders, Bulbs and Valves)
• Ambulatory BP Monitors, Hydration Gear, Illumination Gear, Fire Starters, Repair Kit and Tools, etc.)

By Automated/ Digital Blood Pressure Monitoring Devices Type:

• Upper Arm
• Wrist
• Finger

By Automated/ Digital Blood Pressure Monitoring Devices Technology Type:

• Non-Smart/ Wired
• Smart/ Wireless

By End-User:

• Hospitals & Clinics
• Home Healthcare
• Others

By Distributional Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Stores

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.


Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Adventure Sports Gear industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.






***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents